NCT00159003View on ClinicalTrials.gov

Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 1998

Primary Completion Date

July 1, 2017

Study Completion Date

July 1, 2017

Conditions
Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous Leukemia
Trial Locations (1)

IL91120

Hadassah Medical Organization, Jerusalem

All Listed Sponsors
lead

Deborah Rund

OTHER

NCT00159003 - Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel | Biotech Hunter | Biotech Hunter